[ET Net News Agency, 23 July 2019] Uni-Bio Science Group Limited (00690) said the
company has conditionally agreed to allot and issue an aggregate of 215.8 million
subscription shares to Xinghua Enterprises Limited at the subscription price of HK$0.139
per subscription share.
215.8 million subscription shares represent 3.37% of the issued share capital of the
company as enlarged by the issue of the subscription shares. The subscription price of
HK$0.139 represents a discount of 2.11% to the closing price of HK$0.142 per share on the
last trading day.
The aggregate gross proceeds will be HK$30 million and the aggregate net proceeds are
estimated to be HK$29.9 million. The net proceeds will be used for research and
development expenses over the company's pipeline products oriented to osteoporosis and
diabetes and for general working capital. (RC)